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Toll-like receptors (TLRs) play important roles 
in both innate and adaptive immunity (Kawai 
and Akira, 2010; McGettrick and O’Neill, 2010). 
By recognizing structurally conserved pathogen 
components termed pathogen-associated molec-
ular patterns, TLRs activate signaling through 
the Toll/IL-1R (TIR) domain, which in turn 
triggers  the  binding  of  the  TIR  domain– 
containing adaptors, including myeloid dif-
ferentiation  factor  88  (MyD88),  TIRAP 
(Mal), Toll/IL-1R domain–containing adapter- 
inducing IFN- (TRIF), and TRAM and acti-
vates  specific  signaling  pathways  (Kawai  and 
Akira, 2010; McGettrick and O’Neill, 2010). 
MyD88 activates the IL-1 receptor–associated 
kinases (IRAKs) IRAK4 and IRAK1, which   
finally  activates  IKK-NF-B  and  mitogen- 
activated protein kinases (MAPK; Medzhitov   
et al., 1998). TRIF recruits tumor necrosis factor 
receptor–associated factor 6 (TRAF6) and activates 
transforming growth factor–activated kinase-1 
(TAK1) for NF-B activation (Jiang et al., 2004). 
IFN  regulatory  factor  (IRF)  3  activation  by 
TRIF requires the activation of TANK-binding 
kinase I (TBK1)/IKK, leading to the produc-
tion of type I IFN (IFN-/; Fitzgerald et al., 
2003), which is important for innate elimina-
tion of virus and adaptive induction of CD8+  
T cells (Gautier et al., 2005; Mattei et al., 2009). 
Different from the TRIF-induced activation of 
IRF3,  the  MyD88-dependent  pathway  used   
by TLR2, 5, 7, and 9 can induce type I IFN 
production  by  MyD88-dependent  activation   
of  IRF5  or  IRF7  (Kawai  and  Akira,  2010;   
McGettrick and O’Neill, 2010). Macrophages 
and DCs are professional APCs that are in-
volved in both innate immunity and adaptive 
immunity, mainly by producing cytokines upon 
encountering  various  pathogens.  Despite  the 
fact that the TLR signaling pathway has been 
outlined, more efforts are required for elucida-
tion of molecules involved in the regulation of 
TLR signaling (e.g., assembly of TLR proximal 
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The carboxyl terminus of constitutive heat shock cognate 70 (HSC70)–interacting protein 
(CHIP, also known as Stub1) is a U box–containing E3 ubiquitin ligase that is important for 
protein quality control. The role of CHIP in innate immunity is not known. Here, we report 
that CHIP knockdown inhibits Toll-like receptor (TLR) 4– and TLR9-driven signaling, but 
not TLR3-driven signaling; proinflammatory cytokine and type 1 interferon (IFN) produc-
tion; and maturation of antigen-presenting cells, including macrophages and dendritic 
cells. We demonstrate that CHIP can recruit the tyrosine kinase Src and atypical protein 
kinase C  (PKC) to the TLR complex, thereby leading to activation of IL-1 receptor–
associated kinase 1, TANK-binding kinase 1, and IFN regulatory factors 3 and 7. CHIP acts 
as an E3 ligase for Src and PKC during TLR signaling. CHIP-mediated enhancement of TLR 
signaling is inhibited by IFNAR deficiency or expression of ubiquitination resistant mutant 
forms of Src or PKC. These findings suggest that CHIP facilitates the formation of a TLR 
signaling complex by recruiting, ubiquitinating, and activating Src and PKC.
© 2011 Yang et al.  This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months after   
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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mediate the ubiquitination of diverse proteins, including mem-
brane  receptors,  transcription  factors,  kinases,  and  several 
pathological  proteins  (e.g.,  Ballinger  et  al.,  1999;  Connell   
et al., 2001; Dickey et al., 2007). Knockout of CHIP in mice 
leads to atrophy and temperature-sensitive apoptosis in multi-
ple organs, impairs heat stress responses and protein folding, 
decreases longevity, and accelerates aging (Dai et al., 2003; 
Morishima et al., 2008; Maruyama et al., 2010; Naito et al., 
2010). However, the roles of CHIP in immunity have not 
been elucidated. In the current study, we investigate the effect   
of CHIP on the regulation of TLR signaling in macrophages 
and DCs.
RESULTS
CHIP knockdown inhibits TLR-triggered innate response
We performed a siRNA-based screening of potential E3s in 
regulating APC functions. In BM-derived DCs (BMDCs), we 
examined the effects of knockdown of several E3s (such as 
Cbl-b, GRAIL, A20, SOCS1, TRAF6, ITCH, MARCH-I, 
AIRE, CHIP, etc.) on TLR4-triggered production of TNF 
and IFN- (Fig. S1, A–D). Additionally, we showed that IFN-   
production was not caused by the siRNA duplexes used in 
this study (10 or 30 nM; Fig. S1 E). Knockdown of one of the 
E3s (Fig. S2, A and B), CHIP, could significantly inhibit TNF 
and IFN- production by DCs after stimulation with LPS 
(Fig. S2, C and D). Overexpression of a same-sense CHIP 
mutant resistant to siRNA4 (CHIP-R4) could rescue CHIP 
silence-induced inhibition of TNF and IFN- production 
(Fig. S2, C and D).
CHIP  is  widely  expressed  in  immune  cells,  including 
peritoneal macrophages, RAW264.7 cells, CD11c+ splenic 
DC,  GM-CSF–differentiated  BMDCs  (CD11c+),  Flt-3– 
differentiated plasmacytoid DCs (pDCs; CD11c+B220+), DX5+ 
NK cells, CD4+/CD8+ T cells, and CD20+ B cells (Fig. S3 A). 
As the E3 that contains U box, the role of CHIP in immunity 
has  never  been  elucidated. Therefore,  we  investigated  the   
effects and the underlying mechanisms of CHIP-mediated 
regulation  of TLR  signaling  in  macrophages  and  DCs.  In 
macrophages, knockdown of CHIP by siRNA4 (Fig. S3 B) 
could significantly inhibit IL-6 and IFN- production trig-
gered by TLR2, TLR4, TLR7, and TLR9, but not TLR3, sig-
naling  (Fig.  1).  CHIP  knockdown  could  also  inhibit  the 
production of TNF induced by TLR2/4/7/9 signaling at an 
early stage (1 h after LPS treatments) in macrophages (Fig. S3 C). 
In BMDCs and pDCs, CHIP knockdown (Fig. S3 D) inhib-
ited TLR2/4/7/9 agonist-induced IL-6 and IFN- pro-
duction  (Fig.  1).  Moreover,  CHIP  knockdown  inhibited 
TLR2/4/9-induced  IL-12p70  production  (Fig.  S4 A)  and 
maturation of BMDCs (Fig. S4 B). These results suggest that 
CHIP may be required for TLR2/4/7/9-induced activation 
of macrophages and DCs.
Previously, it has been suggested that extracellular poly(I:C) 
can activate both TLR3 and MDA-5. To confirm whether 
CHIP was involved in TLR3 signaling, we examined the ef-
fects of CHIP silence in poly(I:C)-triggered IRF3 reporter 
activation in TLR3-transfected MDA-5low human embryonic 
complex  and  activation  of  serine-threonine  kinases),  and, 
more importantly, the regulation of APC functions by TLR-
mediated signaling.
The process of protein ubiquitination, which is mediated 
by enzymes known as E1, E2, and E3, and the process of pro-
tein deubiquitination, which is mediated by deubiquitylating 
enzymes (DUBs), play important roles in the modulation of 
immune responses (Liu et al., 2005). For TLR signaling, ef-
fects and mechanisms of several E3 ligases and DUBs have 
been reported (Liu et al., 2005). TRAF6 synthesizes a K63-
linked  polyubiquitin  chain  on  target  proteins,  including 
NEMO and TRAF6 itself, leading to activation of TAK1 and 
NEMO (Deng et al., 2000). In the TRIF-dependent TLR3/4 
signaling  pathway, TRAF3  is  essential  for  the  K63-linked 
ubiquitination of TANK (Gatot et al., 2007). In contrast to 
K63-linked polyubiquitination and activation, the K48-linked 
polyubiquitination can target the substrates to proteasome 
degradation, restricting the innate immune response (Liu   
et al., 2005). Several E3s have been implicated in the negative 
regulation of TLR signaling, such as Triad3A, SOCS1, Cbl-b, 
PDLIM2, A20, and Itch (Liu et al., 2005; Kawai and Akira, 
2010; McGettrick and O’Neill, 2010). Therefore, the manner 
of ubiquitination by E3 and the contact of ubiquitinated sub-
strates with DUBs may decide the intensity and the fate of 
TLR signaling components. Many efforts have been put into 
the study of E3-mediated regulation of T cell signaling (Liu   
et al., 2005). However, the functional regulation of APCs, 
which are the bridge between innate immunity and adaptive 
immunity, by E3s and underlying mechanisms has not been 
completely elucidated (Gautier et al., 2005; Liu et al., 2005; 
Mattei et al., 2009; Kawai and Akira, 2010; McGettrick and 
O’Neill, 2010).
We have previously demonstrated that the E3 ligase Nrdp1 
can modulate the ubiquitination of MyD88 and TBK1, lead-
ing to preferential IFN- production (Wang et al., 2009). 
Type I IFN produced by APCs such as DCs and macrophages, 
plays an important role in regulating the cytokine production, 
survival, maturation, and antigen presentation of APCs by ac-
tivating  IFN-/  receptor  (IFNAR)–mediated  transcrip-
tional regulation of type I IFN-induced genes (Gautier et al., 
2005; Mattei et al., 2009; Kawai and Akira, 2010; McGettrick 
and O’Neill, 2010). To elucidate the mechanisms involved in 
the functional regulation of APCs, we screened and investi-
gated the effects of E3s in regulating TLR-mediated cytokine 
production by using small interfering RNAs (siRNAs) for 
E3s in DCs. We found that knockdown of one of the E3s,   
the carboxyl terminus of constitutive heat shock cognate 70 
(HSC70)–interacting protein (CHIP; also known as Stub1), 
significantly  inhibited  LPS  (for TLR4)  and  unmethylated 
CpG oligodeoxynucleotides (CpG ODN or CPG; for  TLR9)-
induced production of IFN-. Previous studies suggest that 
CHIP contains a ring finger-like U box domain and acts as 
E3  in  combination  with  chaperones  heat  shock  protein   
70 (HSP70) and HSP90 to mediate the ubiquitination of 
chaperone-bound substrates (Ballinger et al., 1999; Connell   
et al., 2001; Dickey et al., 2007). CHIP has been reported to JEM Vol. 208, No. 10 
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we found that 
the activation 
of IL-6, CCL5, and IFN- reporters were also significantly 
impaired in RAW264.7 cells after CHIP knockdown (Fig. 2 C), 
indicating that CHIP knockdown-induced decrease of IL-6 
and IFN- production (Fig. 1) may be caused by decreased 
NF-B and IRF3 activation. We also found that CHIP over-
expression in RAW264.7 cells led to increased IL-6 and IFN- 
production and NF-B and IRF3 reporter activation (un-
published data).
To further examine the effects of CHIP knockdown on 
NF-B and IRF3/7 activation, we examined the DNA-binding 
capacity and nuclear translocation of NF-B and the nu-
clear translocation of IRF3/7. In CHIP-silenced RAW264.7 
cells, the nuclear presence of p50, p65, IRF3, and IRF7 after 
LPS/CpG treatments was decreased (Fig. 3 A). Moreover, the 
DNA-bound NF-B levels and nuclear IRF3/7 levels were 
reduced in CHIP-silenced RAW264.7 cells (Fig. 3, B and C). 
In BMDCs, CHIP knockdown inhibited TLR4/9-triggered 
NF-B  activation  (Fig.  3  D)  and  nuclear  translocation  of 
IRF3 and IRF7 (Fig. 3 E). Similarly, CHIP knockdown in-
hibited TLR9-triggered NF-B activation (Fig. 3 D) and nu-
clear translocation of IRF3 and IRF7 in pDCs (Fig. 3 E).
CHIP interacts with Src, protein kinase C  (PKC),  
and TRAF6
CHIP was initially identified as an E3 interacting with HSP70 
and HSP90 (Ballinger et al., 1999; Connell et al., 2001; Dickey 
et al., 2007). However, its molecular mechanisms involved in 
TLR response have not been examined. In LPS/CpG-treated 
RAW264.7 cells, we found that CHIP, together with MyD88, 
TRIF, IRAK1, TBK1, TRAF6, HSC70, Src, or PKC, could 
be coimmunoprecipitated with TLR4 and TLR9 (but not 
TLR3; Fig. 4 A), indicating that CHIP may be a component 
of a TLR4/9 complex that initiates signaling.
Next, we investigated the CHIP-associated molecules by 
using recombinant GST fusion proteins (Fig. 4 B, top). By   
using cell lysates from RAW264.7 cells, we found that CHIP 
can associate with HSC70, PKC, Src, and TRAF6 (Fig. 4 B, 
middle),  but  not  MyD88, TRIF,  IRAK1,  and TBK1  (not   
depicted), which suggests the possible association of CHIP 
with  HSC70,  PKC,  Src,  and TRAF6. To  verify  whether 
CHIP can directly interact with these targets, we performed 
kidney  293  (HEK293)  cells  and  in  MDA5/  MEFs. We 
found that poly(I:C) treatments could activate IRF3 reporter 
in both cells while CHIP silence didn’t affect the effects of 
poly(I:C) (Fig. S5, A–C), indicating that CHIP may be not 
required for TLR3 signaling.
CHIP knockdown inhibits NF-B and IRF3/7
To look into the potential signaling pathways regulated by 
CHIP, we performed reporter assays in RAW264.7 cells that 
were stably transfected with CHIP RNA interference vector 
(RNAi; Fig. 2 A). We found that CHIP knockdown inhibited 
LPS/CpG-induced activation of NF-B and IRF3 reporters 
(Fig. 2 B), whereas the AP1 reporter activation by LPS/
CpG was not affected (unpublished data). Correspondingly, 
Figure 1.  Silencing of CHIP impairs TLR-triggered 
innate response in macrophages and DCs.  
48 h after transient transfection of 30-nM siRNAs in 
indicated cells, the cells were treated with 160 ng/ml 
Pam3Cys (Pam3), 10 µg/ml poly (I:C) (p[I:C]), 100 ng/ml 
LPS, 2 µg/ml R848, or 1 µM CpG ODN for 4 h (for 
macrophages) or 8 h (for DCs). Results were pre-
sented as mean concentration (picogram/milliliter) of 
indicated cytokines in the culture supernatants ± SD 
of triplicate samples. CTRL, scrambled control siRNAs; 
PM, peritoneal macrophages; BMDCs, BM-derived 
DCs; pDCs, plasmacytoid DCs; ns, not significant;  
*, P < 0.05; **, P < 0.01; ***, P < 0.001. The data 
shown correspond to a representative experiment  
out of three performed.
Figure 2.  Silencing of CHIP impairs TLR signaling pathways.  
(A) RAW264.7 cells were transfected with plasmids encoding siRNAs, and 
selected with 600 µg/ml neomycin. The efficiency of silencing was evalu-
ated by Western blot. CTRL, scrambled control RNAi; RNAi, CHIP-specific 
RNAi. (B and C) Reporter assays in RAW264.7 cells. Cells in A were tran-
siently transfected with NF-B or IRF3 reporters (B) or IL-6, CCL5, or IFN-  
promoter reporters for 48 h, and then treated with 100 ng/ml LPS, 10 µg/ml 
poly (I:C), or 1 µM CpG ODN for 4 h. Results were expressed as fold induc-
tion relative to the luciferase activity in unstimulated cells transfected 
with control vector. Data are shown as mean ± SD of triplicate samples. 
ns, not significant; *, P < 0.05; **, P < 0.01. The data shown correspond to 
a representative experiment out of three performed.2102 CHIP E3 ligase facilitates TLR signaling | Yang et al.
poly(I:C)-triggered activation of NF-B and IRF3-IFN- re-
porters (Fig. 2, B and C), we found that CHIP knockdown didn’t 
affect the recruitment of Src to TLR3 complex (Fig. S5 D).
Accordingly, we found that LPS/CpG-induced activation 
of Src and PKC was inhibited by CHIP knockdown, as   
indicated by decreased tyrosine phosphorylation of Src, de-
creased threonine phosphorylation of PKC (Fig. 5 B), and 
decreased  kinase  activities  of  endogenous  Src  and  PKC  
(Fig. S6 A). In RAW264.7 cells stably transfected with CHIP-HA,   
LPS/CpG-induced  activation  of  Src  and  PKC  was  en-
hanced (Fig. 5 C and Fig. S6 B). Furthermore, we found that 
Src inhibitor PP1 could decrease the phosphorylation and   
kinase activity of PKC, and the pseudosubstrate of PKC 
(PS) could decrease the phosphorylation and kinase activity 
of Src (Fig. 5 C and Fig. S6 B), indicating that an interplay 
may exist between the recruited Src and PKC. These data 
suggest that CHIP recruits and activates Src and PKC in 
TLR response.
CHIP promotes TLR signaling  
via Src and PKC
We  have  shown  that  CHIP  knock-
down  inhibited  TLR4/9-induced   
activation  of  NF-B  and  IRF3/7   
(Fig. 2 and Fig. 3). However, the mecha-
nisms responsible for CHIP-mediated 
effects in TLR response have not been 
elucidated.  Thus,  we  examined  the   
activation status of IKK/ and IB 
molecules, as well as TBK1 and IRAK1, 
GST pull-down assays using recombinant proteins, and found 
that CHIP could directly bind HSC70/PKC/Src via TPR 
domain (Fig. 4 B, bottom).
To  further  verify  these  interactions,  we  coexpressed   
HA-tagged CHIP with Flag-tagged HSC70, PKC, Src, or 
TRAF6 in HEK293 cells and found that CHIP can associate 
with these Flag-tagged molecules (Fig. 4 C) and may associate 
with TRAF6 indirectly via HSC70 (Fig. 4, B and C).
CHIP recruits and activates Src and PKC
Next, we investigated the effects of CHIP in TLR signaling 
components. In CHIP-silenced RAW264.7 cells, LPS/CpG-
induced recruitment of Src and PKC by TLR4/9 was de-
creased, whereas the recruitment of HSC70 and TRAF6 by 
TLR4/9  was  not  affected  (Fig.  5 A). The  recruitment  of 
MyD88, TRIF, IRAK1, and TBK1 by TLR4/9 was not af-
fected by CHIP knockdown (unpublished data). Consistent 
with the observations that CHIP knockdown didn’t affect 
Figure 3.  CHIP knockdown inhibits NF-B  
and IRF3/7. (A) RAW264.7 cells stably trans-
fected with scrambled control vector 
(RAW264.7-CTRL) or CHIP silencing vector 
(RAW264.7-CHIP RNAi) were treated with  
100 ng/ml LPS or 1 µM CpG ODN for 1 h. Next, the  
intracellular translocation of p50, p65, IRF3, 
and IRF7 were evaluated by confocal micros-
copy using primary antibodies (Ab) specific for 
the indicated proteins and Oregon Green 
488–conjugated secondary antibody. Bar,  
150 µm. (B and C) Cells in A were lysed and nu-
clear extracts were isolated. Next, DNA-binding 
capacity of NF-B was examined by EMSA  
(B), and the nuclear translocation of IRF3/7 was 
examined by Western blot (C). For supershift 
assays in B, 1 µg of control IgG, anti-p50, or anti-
p65 antibodies, where indicated, were incu-
bated for 30 min on ice before the adding of 
probes. (D and E) 48 h after transient trans-
fection of siRNAs in day 6 BMDCs and day 10 
pDCs, the cells were treated with indicated 
TLR agonists for 1 h, and nuclear extracts 
were used in EMSA assays (D) or examined for 
nuclear IRF3/7 by Western blot (E). The data 
shown correspond to a representative experi-
ment out of three performed.JEM Vol. 208, No. 10 
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As demonstrated in Figs. 1–3, CHIP knockdown inhib-
ited TLR-triggered activation of IRF3/7-IFN- more sig-
nificantly than TLR4/9-triggered activation of NF-B. Because 
CHIP promoted degradation of IB (Fig. 6 A), which may 
explain  CHIP-potentiated  NF-B  activation,  we  decided   
to  examine  the  effects  of  IRAK1  and  TBK1  activation   
on IRF3/7 by using recombinant IRF3 and IRF7 as sub-
strates in the in vitro kinase assays. We found that IRAK1   
and TBK1 immunoprecipitated from CHIP-overexpressed 
RAW264.7 cells could potently increase the levels of phos-
phorylated IRF3 and IRF7 in vitro, which could be attenu-
ated by transient transfection of SrcY416F and PKCT410A 
(Fig. 6, D and E). Therefore, a CHIP-mediated increase in 
IL-6 and IFN- production during TLR response may be 
caused  by  Src/PKC-dependent  activation  of  IB  and 
IRAK1/TBK1, respectively.
Knockdown of Src and PKC blocks 
the effects of CHIP in TLR response
To further explore the roles of Src and 
PKC in CHIP-mediated effects dur-
ing TLR response, we silenced the ex-
pression of Src and PKC with siRNAs 
in  CHIP-overexpressed  RAW264.7 
cells (Fig. 7 A). We found that knock-
down of Src and PKC could block 
CHIP overexpression–induced activa-
tion of NF-B reporters after LPS/CpG 
treatments (Fig. 7 B), and the nuclear 
translocation of IRF3 and IRF7 were 
also decreased after knockdown of Src 
and PKC (Fig. 7 C). These data sug-
gest that Src and PKC were both re-
quired for CHIP-mediated effects in 
TLR4/9 response.
molecules upstream of NF-B and IRF3/7, respectively. We 
found that in CHIP-overexpressed RAW264.7 cells and CHIP-
silenced RAW264.7 cells LPS/CpG-induced phosphoryla-
tion of ERK1/2 (Thr202/Tyr204), JNK1/2 (Thr183/Tyr185), 
p38 (Thr180/Tyr182), and IKK/ (Ser176/180) were not sig-
nificantly affected by CHIP expression levels (unpublished data). 
Although the LPS/CpG-induced phosphorylation of IB 
(Ser32/36) was not affected, CHIP overexpression promoted 
LPS/CpG-induced degradation of IB (Fig. 6 A) and kinase 
activity of IRAK1 and TBK1 (Fig. 6 B). More importantly, the 
Src inhibitor PP1 and PKC pseudosubstrate could block these 
CHIP-mediated effects (Fig. 6, A and B). In CHIP-silenced 
RAW264.7  cells,  the  LPS/CpG-induced  increase  in  kinase   
activity of IRAK1 and TBK1 was impaired (Fig. 6 C). These 
data suggest that CHIP may be required for the activation of 
IB, IRAK1, and TBK1 through activation of Src/PKC.
Figure 4.  CHIP binds HSC70, Src and 
PKC. (A) Wild-type RAW264.7 cells were 
treated with 100 ng/ml LPS, 10 µg/ml poly 
(I:C), or 1 µM CpG ODN, as indicated, and 
whole-cell lysates (WCL) were prepared. TLR4, 
TLR9, and TLR3 were immunoprecipitated (IP) 
with corresponding antibody plus protein A/G 
beads, and then components in immune com-
plex were examined by Western blot. (B) GST 
fusion proteins were confirmed by immuno-
blot (IB) using GST antibody (top). GST pull-
down assays were performed using lysates 
(WCL) from RAW264.7 cells (middle) or re-
combinant proteins (bottom). *, 30 µg lysates; 
**, 1 ng recombinant proteins. (C) HEK293 cells 
were co-transfected with plasmids encoding 
HA-tagged CHIP or mutants and plasmids 
encoding Flag-tagged target molecules. 48 h 
later, immunoprecipitation assays were per-
formed using anti-HA agarose or IgG agarose (*).
The data shown correspond to a representa-
tive experiment out of three performed.2104 CHIP E3 ligase facilitates TLR signaling | Yang et al.
N-terminal myristoylation signal) mu-
tant was mainly localized in cytosol of 
RAW264.7 cells (Fig. 8 A). In LPS-
treated RAW264.7 cells, CHIP was par-
tially colocalized with TLR4, Src, and 
PKC (Fig. 8 B, rows 1–3), suggesting 
that CHIP may recruit Src and PKC 
onto endosomes during TLR4 response. 
Additionally,  we  found  that  Src  and 
PKC could be recruited to TLR4 after 
LPS treatments (Fig. 8 B, rows 4 and 5).
Because CHIP is a U box–containing E3, we examined 
the ubiquitination status of Src and PKC in CHIP-silenced 
RAW264.7 cells and found that CHIP knockdown inhibited 
LPS-induced K63-linked polyubiquitination of both Src and 
PKC (Fig. 9, A and B). To verify the effects of E3 activity of 
CHIP on Src and PKC, we performed in vitro polyubiqui-
tination assays in the presence of two popular E2s, UbcH5A, 
and UbcH13/Uev1A. We found that GST-CHIP could me-
diate the polyubiquitination of Src and PKC in the presence 
of both E2s (Fig. 9 C). To verify the ubiquitination forms of 
Src and PKC by CHIP, we applied recombinant ubiquitin 
containing K63 only (UbK63O) or ubiquitin containing K48 
only (UbK48O) in the assays. We found that CHIP could 
mediate both K48-linked and K63-linked polyubiquitination 
of Src and PKC in vitro (Fig. 9 C).
Next, we determined the potential ubiquitinated sites in 
Src/PKC that were modified by CHIP. First, we predicted 
the ubiquitination sites by using the Bayesian discriminant 
method-prediction of ubiquitination sites algorithm. Second, 
We have shown that CHIP could promote the kinase activity 
of IRAK1 and TBK1 (Fig. 6, B–E). However, the mechanisms 
responsible for Src/PKC activation-induced enhancement of 
IRAK1 and TBK1 activities were not revealed. Therefore, we 
examined the effects of Src/PKC knockdown on CHIP-
mediated IRAK1 and TBK1 activation after LPS treatments. 
Considering that Src is a tyrosine kinase and that PKC is a   
serine/threonine kinase, we examined the phosphorylation of 
IRAK1 and TBK1 using phosphotyrosine-, phosphoserine-, and 
phosphothreonine-specific  antibodies. We  found  that  knock-
down of Src/PKC could inhibit CHIP-mediated increase in 
the phosphorylated levels of IRAK1 and TBK1 (Fig. 7 D), indi-
cating that CHIP may promote the activation of Src/PKC, 
which, in turn, phosphorylated and activated IRAK1/TBK1.
CHIP colocalizes with and polyubiquitinates Src and PKC
The  N  terminus  of  CHIP  contains  a  myristoylation  site.   
We found that CHIP was mainly localized within (EEA1-
positive) endosomes, whereas the CHIPN20 (deletion of 
Figure 5.  CHIP knockdown inhibits 
TLR4/9-induced recruitment and activa-
tion of Src and PKC. (A) RAW264.7 cells 
stably transfected with CHIP-specific RNAi 
(RNAi) or scrambled control RNAi (CTRL) were 
treated with 100 ng/ml LPS or 1 µM CpG ODN, 
as indicated. TLR4 and TLR9 were immunopre-
cipitated (IP) with corresponding antibody 
plus protein A/G beads. Next, components in 
immune complex were examined by Western 
blot. WCL, whole-cell lysates. (B) Cell lysates 
derived from cells in A were immunoprecipi-
tated with Src or PKC antibody or IgG plus 
protein A/G beads. Activation of Src (p-Src, 
phospho-Src) and PKC (p-PKC, phospho-
PKC) was evaluated by immunoblot (IB)  
using phospho-specific antibodies. (C) RAW264.7 
cells stably transfected with mock control 
vector or HA-tagged CHIP vector (CHIP-HA), 
pretreated with or without 10 nM Src inhibitor 
(PP1) or 10 µM PKC pseudosubstrate peptide 
(PS) for 30 min, were treated with 100 ng/ml 
LPS or 1 µM CpG ODN, as indicated.  
Activation of Src and PKC were evaluated  
as described in B. The data shown correspond  
to a representative experiment out of  
three performed.JEM Vol. 208, No. 10 
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and PKC by CHIP 
may  be  crucial  in 
CHIP-mediated ef-
fects on regulating TLR response.
To look into the effects of localization and E3 activity of 
CHIP, we stably overexpressed CHIPN20 and CHIPH261Q 
(E3 activity deficiency) in RAW264.7 cells. We found that 
LPS and CpG-induced kinase activities of Src and PKC 
were  significantly  decreased  (Fig.  S7 A).  Interestingly,  we 
found that production of IL-6 and IFN- was significantly 
inhibited  in  RAW264.7  cells  stably  overexpressing 
CHIPN20 and CHIPH261Q (Fig. S7 B). These data to-
gether suggest that CHIP-mediated effects in TLR response 
may require both the endosomal localization and the E3 ac-
tivity of CHIP.
CHIP promotes DC maturation
In BMDCs, knockdown of CHIP decreased the recruitment 
of Src and PKC to the TLR4/9 complex (Fig. S8 A), im-
paired the kinase activity of Src and PKC (Fig. S8 B), inhib-
ited the kinase activity of IRAK1 and TBK1 (Fig. S8 C), and 
attenuated the expression of IL-12p40 and CD40 (Fig. 10 A). 
These data confirm that CHIP-mediated recruitment and   
we performed multiple alignment of Src/PKC protein se-
quences derived from various species (for evolution conserva-
tion; unpublished data). By these 2 rounds of selection, Src 
may contain 20 ubiquitination sites, and PKC may contain 9 
ubiquitination sites (Fig. 9 D). To verify these ubiquitination 
sites, we constructed 12 mutants for Src and 6 mutants for 
PKC, and examined the ubiquitin levels associated with Src/
PKC after LPS treatments in RAW264.7 cells using ELISA. 
We found that Src-K5/7/9R and Src-K324/329R mutations 
could  most  significantly  abolish  the  polyubiquitinated  Src 
levels,  whereas  PKC-K220/225R  could  effectively  block 
the polyubiquitinated levels of PKC (Fig. 9 E). These data 
suggest that K5/7/9 and K324/329 in Src, and K220/225   
in PKC, may be the major ubiquitination sites modified 
during TLR4 response.
To verify whether these sites were modified by CHIP, we 
transfected these mutants into CHIP-overexpressed cells. We 
found that polyubiquitination of Src-K5/7/9R, Src-K324/
329R, and PKC-K220/225R was impaired, as compared with 
wild-type Src or PKC (Fig. 9 F). More importantly, Src-K5/
7/9R, Src-K324/329R, and PKC-K220/225R transfection 
could block the effects of CHIP in activating NF-B and IFN- 
reporters (Fig. 9, G and H). Therefore, polyubiquitination of Src 
Figure 6.  CHIP promotes TLR-triggered 
Src- and PKC-dependent activation of 
IB, IRAK1, and TBK1. (A) Western blot 
assays of signaling mediators in RAW264.7 
cells stably transfected with mock control 
vector or HA-tagged CHIP vector (CHIP-HA) 
and treated with 100 ng/ml LPS or 1 µM CpG 
ODN, as indicated. Otherwise, cells were pre-
treated with 10 nM Src inhibitor (PP1) or 
PKC 10 µM pseudosubstrate peptide (PS)  
for 30 min before LPS or CpG stimuli.  
(B and C) In vitro kinase assays of IRAK1 and 
TBK1. In B, RAW264.7 cells stably transfected 
with mock control vector or HA-tagged CHIP 
vector (CHIP-HA) were used. In C, RAW264.7 
cells stably transfected with scrambled control 
RNAi (CTRL) or CHIP-specific RNAi (RNAi) 
were used. These cells were treated with  
100 ng/ml LPS or 1 µM CpG ODN for 30 min. 
Kinase activity of immunoprecipitated (IP) 
IRAK1 and TBK1 was evaluated by in vitro 
kinase assays in the presence of 1 µCi of  
[-32P]-ATP (6,000 Ci/mmol) and 0.5 µg of MBP 
as substrate. (D and E) In vitro kinase assays 
of IRAK1 and TBK1. Cells in A were transiently 
transfected with mock vector or Flag-tagged 
SrcY416F or PKCT410A mutant vector for 48 h. 
After treatment with 100 ng/ml LPS or 1 µM 
CpG ODN for 30 min, the kinase activity of immuno-
precipitated (IP) IRAK1 and TBK1 was evaluated 
by in vitro kinase assays in the presence of 1 µCi 
of [-32P]-ATP (6,000 Ci/mmol) and 0.5 µg of 
IRF3 (D) or IRF7 (E) as substrates. In B–E, re-
sults were presented as mean radioactivity ± 
SD of triplicate samples. ns, not significant;  
*, P < 0.05; **, P < 0.05; ***, P < 0.001. The data 
shown correspond to a representative experi-
ment out of three performed.2106 CHIP E3 ligase facilitates TLR signaling | Yang et al.
possibly TLR2/7 
complexes,  but 
not TLR3 com-
plex,  within  en-
dosomes.  Our 
data suggest that   
CHIP  knock-
down doesn’t affect the TLR3 recruitment of Src and other 
signaling molecules and the activation of IRF3-IFN- by 
poly(I:C), indicating that CHIP may be dispensable for TLR3 
signaling. One possibility is that TLR3 may directly recruit 
Src, whereas TLR4/9 may recruit Src via a scaffold protein. 
The differences between CHIP-mediated effects on regula-
tion of TLR4/9 signaling versus TLR3 signaling may thus 
need further investigations. Moreover, the CHIP-mediated 
effects on TLR response may need to be further verified in 
CHIP/  mice,  which  are  now  commercially  unavailable, 
and the possibility that CHIP-mediated regulation of TLR 
response may be involved in CHIP knockout-induced atro-
phy of multiple organs and cell apoptosis needs additional 
study. However, our data demonstrate that stable silence of 
CHIP in RAW264.7 cells and transient knockdown of CHIP 
in BMDCs and pDCs can inhibit TLR2/4/7/9 signaling- 
triggered cytokine production and TLR4/9-induced activation 
of Src–PKC-IRAK1–TBK1-IRF3–NF-B signaling path-
way, which strongly and clearly outline the signaling mecha-
nisms of CHIP in TLR response.
Endosomes are the major sites of TLR complex assembly 
(Kawai and Akira, 2010; McGettrick and O’Neill, 2010). It 
has been shown that TLR4 in endosomes may associate with 
TRIF-TBK1 and regulate IFN-/ production (Kagan et al., 
2008). More typically, TLR7/9 and TLR3 have been sug-
gested to initiate antiviral response and type I IFN produc-
tion  in  endosomes  or  endolysosomes  (Kawai  and  Akira,   
2010;  McGettrick  and  O’Neill,  2010). Therefore,  CHIP- 
mediated  assembly  of TLR  complex  may  be  an  essential 
mechanism for TLR-triggered type I IFN production. How-
ever, our study suggests that CHIP may be not involved in 
activation of Src and PKC are also required for DC activa-
tion and maturation upon TLR4/9 signaling.
Type I IFN-mediated signaling play important roles in 
maturation of DCs (Gautier et al., 2005; Mattei et al., 2009). 
Thus, to examine the effects of CHIP in LPS/CpG-induced 
maturation of DCs, we measured the production of IFN-  
in BMDCs after CHIP overexpression. We found that CHIP 
could  significantly  increase  the  levels  of  IFN-,  whereas 
CHIPN20 and CHIPH261Q could inhibit the production 
of IFN- after LPS/CpG treatments (Fig. 10 B). Moreover, 
Src  inhibitor  PP1,  PKC  pseudosubstrate,  kinase  inactive 
form of Src, and PKC could block CHIP-mediated increase 
in IFN- production (Fig. 10 B).
To further elucidate the roles of CHIP in LPS/CpG- 
induced maturation of DCs, we used the BMDC-derived from 
IFNAR/ mice. We found that CHIP overexpression in   
IFNAR/ BMDCs failed to promote LPS/CpG-induced 
maturation of DCs (Fig. 10, C and D), which indicated that 
CHIP-mediated  type  I  IFN  production  was  required  for 
LPS/CpG-induced DC maturation.
DISCUSSION
Here, we have identified the function and the underlying 
mechanisms of CHIP in the regulation of TLR signaling in 
APC. We demonstrate that CHIP can orchestrate the TLR4/9 
signaling  pathway  by  recruiting  and  activating  Src/PKC, 
enhancing kinase activity of IRAK1/TBK1 and promoting 
degradation of IB, which lead to activation of NF-B and 
IRF3/7 and activation/maturation of macrophages and DCs. 
Thus, CHIP may be the first U box–containing E3 identified 
in mammalian TLR response. Previous studies have identified 
CMPG1 as a potential regulator of plant defense machinery 
(González-Lamothe et al., 2006) and Act1/CIKS has been 
shown to interact with TRAF6 (Kanamori et al., 2002). How-
ever, these U box–containing E3s have not been investigated 
for their roles in  TLR response in APCs. Our study suggests that 
CHIP, the endosome-associated U box-containing E3, may be a 
scaffold molecule orchestrating the assembly of TLR4/9 and   
Figure 7.  Knockdown of Src and PKC 
blocks the effects of CHIP in TLR response.  
(A) RAW264.7 cells stably transfected with mock 
vector or CHIP-HA vector were transiently trans-
fected with control siRNAs (CTRL, for GFP) or Src/
PKC-specific siRNAs for 48 h. The efficiency of 
silencing was evaluated by Western blot. (B) Cells 
in A were transiently transfected with NF-B 
reporters for 48 h. Cells were treated with 100 ng/ml 
LPS or 1 µM CpG ODN for 4 h. Results were  
expressed as fold induction relative to the activity 
in unstimulated cells transfected with mock vec-
tor. Data are shown as mean ± SD of triplicate 
samples. si-Src, siRNAs specific for Src; si-PKC, 
siRNAs specific for PKC; ns, not significant;  
**, P < 0.01; ***, P < 0.001 (as compared with cor-
responding cells without LPS/CpG treatments).  
(C and D) Cells in A were treated with 100 ng/ml 
LPS for 1 h (C) or 30 min (D), and then nuclear 
extracts (C) and cell lysates (D) were prepared. 
Nuclear translocation of IRF3/7 (C) or phosphory-
lated IRAK1/TBK1 within immunoprecipitates (IP; D) 
was examined by Western blot. s-1, control siRNAs 
for GFP; s-2, Src-specific siRNAs; s-3, PKC-specific 
siRNAs. The data shown correspond to a repre-
sentative experiment out of three performed.JEM Vol. 208, No. 10 
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TLR3  complex  formation,  indicating  that TLR2/4/7/9 
complex components may be different to those of TLR3. The 
observation that HSC70 is not immunoprecipitated with TLR3 
may suggest that CHIP recruitment to TLR complex may be 
through HSC70, which may be the reason for CHIP inability 
to regulate TLR3 response. One potential inconsistency in 
our study is the observation that CHIP is a component of 
both TLR4–MyD88–IRAK1 and TLR4–TRIF–TBK1 com-
plexes  (Kawai  and Akira,  2010;  McGettrick  and  O’Neill, 
2010). The assembly of TLR4 complex mainly occurs at   
the  proximal  intracellular  region  of  TLR4  that  recruits 
MyD88 and MyD88-associated molecules, which may acti-
vate NF-B and MAPK to initiate proinflammatory cytokine 
production; although after internalization, TLR4 can com-
plex with TRIF and TRIF-associated molecules, which may 
activate TBK1-IRF3/7  to  initiate  type  I  IFN  production 
(Kagan et al., 2008; Kawai and Akira, 2010; McGettrick and 
O’Neill, 2010). In our study, we found that CHIP can poten-
tiate the effects of LPS and CpG in the production of IFN- 
and IL-6, indicating that a portion of TLR4 complex forma-
tion may also exist in endosomes. Considering that plasma 
membrane TLR4 can be translocated from cell surface to endo-
somes rapidly (within 10 min; Wang et al., 2007), CHIP- 
mediated effects in  TLR response may take place in endosomes. 
However, it remains to be determined whether TLR4–MyD88–
IRAK1 assembly partially occurs within endosomes.
LPS-initiated,  MyD88-dependent  signaling  pathways   
can activate MAPK and NF-B via sequential activation of 
MyD88–IRAK–TRAF6, resulting in production of proinflam-
matory cytokines (IL-1, IL-6, TNF, etc.; Medzhitov et al., 1998; 
Takaesu et al., 2000). LPS can also initiate TRIF-dependent 
activation of IRF3/7 to regulate the IFN-inducible genes 
(CXCL10,  IFN-/,  etc.;  Fitzgerald  et  al.,  2003;  Sharma   
et  al.,  2003;  Jiang  et  al.,  2004;  Kawai  and  Akira,  2010;   
McGettrick and O’Neill, 2010). Our study demonstrates that 
CHIP can regulate the IL-6 production and IFN- produc-
tion induced by TLR4/9. We also show that CHIP modulates 
the activation of IRAK1 and TBK1 through Src and PKC. 
Therefore, the effects of CHIP in TLR response may rely on 
activation of Src and PKC, which are confirmed by the   
experiments  that  Src/PKC  inhibitors,  dominant-negative 
Src/PKC, and Src/PKC siRNAs impaired the effects of 
CHIP in regulating TLR response.
Protein tyrosine kinases, such as Btk, Syk, and Src, have 
been reported to regulate TLR response (Kawai and Akira, 
2010; McGettrick and O’Neill, 2010). It has been shown that 
Btk can phosphorylate TLR4 and Mal, which are required for 
TLR4-triggerred  NF-B  activation  (Jefferies  et  al.,  2003; 
Gray et al., 2006). Src inhibitors can inhibit TLR4 and TLR9 
signaling (Stovall et al., 2004; Medvedev et al., 2007). Syk has 
been shown to regulate TLR signaling pathways (Zhang et al., 
2009). For the Src family of tyrosine kinases, it has been dem-
onstrated that Src can potentiate both TLR4 and TLR3 sig-
naling (Smolinska et al., 2008; Kuka et al., 2010). Src has also 
been implicated in the TRIF–TBK1–IRF3 complex during 
poly(I:C)-induced TLR3  signaling  (Johnsen  et  al.,  2006).   
Figure 8.  CHIP colocalizes with Src and PKC. (A) Localization of 
CHIP in endosomes. RAW264.7 cells were transiently transfected with 
GFP-tagged CHIPN20 or CHIP vector for 48 h. Cells were stained with 
anti-EEA1 and Alexa Fluor 555–conjugated secondary antibody. Bars,  
100 µm. (B) RAW264.7 cells were transiently transfected with CHIP-GFP for 
48 h, and treated with 100 ng/ml LPS for 10 min (rows 1–3). Cells were 
stained with anti-TLR4, Src, PKC antibodies, and Alexa Fluor 555– 
conjugated secondary antibody. RAW264.7 cells were treated with 100 ng/ml 
LPS for 10 min (rows 4 and 5). Cells were stained with anti-TLR4, Src, or 
PKC antibodies, and Oregon Green 488-conjugated or Alexa Fluor 555–
conjugated secondary antibody. In B, the merged images are shown. The 
boxed regions in the middle image were correspondingly magnified and 
shown on the right. White arrow heads indicated for the typical colocal-
ization sites. Bars, 100 µm. The data shown correspond to one representa-
tive experiment out of three performed.2108 CHIP E3 ligase facilitates TLR signaling | Yang et al.
interplay exists between Src and atypical PKCs, and Src can 
mediate  the  tyrosine  phosphorylation  of  PKC  (Wooten   
et al., 2001). Our study suggests that CHIP-mediated Src and 
PKC activation may lead to activation of IRAK1 and TBK1, 
which has been confirmed by using Src/PKC inhibitors, 
dominant-negative Src/PKC, and Src/PKC siRNAs. Given 
that IRAK1 can activate IRF7 and that TBK1 can activate 
IRF3/7 (Sharma et al., 2003; Uematsu et al., 2005), it may be 
For atypical PKC/, evidence suggests that they are involved 
in the regulation of TLR response (Monick et al., 2000;   
Cuschieri et al., 2004; Teusch et al., 2004). It has been shown 
that PKC can directly phosphorylate IRAK1 in Thr66 and 
promote autophosphorylation of IRAK1 (Mamidipudi et al., 
2004). Therefore, current data suggest a potential involvement 
of Src and PKC in TLR response by regulating phosphory-
lation and activity of IRAK1 or TBK1. More importantly, an 
Figure 9.  CHIP polyubiquitinates Src and PKC. (A and B) In vivo polyubiquitination assays. RAW264.7 cells stably transfected with scrambled con-
trol RNAi (CTRL) or CHIP-specific RNAi (RNAi) were treated with 100 ng/ml LPS or 1 µM CpG ODN for 30 min. Src and PKC contained in lysates were then 
subjected to heat denaturing in 1% SDS and immunoprecipitated (IP) with Src (A) or PKC (B) antibody plus protein A/G agarose. Ubiquitination was  
examined by immunoblot (IB) using anti-ubiquitin (Ub), anti–K63-Ub, or anti–K48-Ub antibody as indicated. (C) In vitro polyubiquitination assays. GST-CHIP 
was incubated with recombinant Src or PKC in the presence of E1, His6-Ub derivatives, and UbcH5A or Ubc13/Uev1A E2/Ubc as indicated. Src and PKC 
were immunoprecipitated (IP) with anti-Src or anti-PKC antibody after heat denaturing in 1% SDS. UbK63O, ubiquitin containing only Lys63; UbK48O, 
ubiquitin containing only Lys48. (D) Predicted ubiquitination sites in Src and PKC using the Bayesian discriminant method-prediction of ubiquitination 
sites algorithm, as well as protein sequence alignment. (E) RAW264.7 cells were transiently transfected with Flag-tagged wild-type or mutant Src (left) or 
PKC (right) constructs for 48 h, and then treated with 100 ng/ml LPS for 30 min. Ubiquitin levels associated with Src/PKC (mutants) were evaluated by 
ELISA at 450 nm. 1 ng recombinant ubiquitin-His was used as positive control. (F) RAW264.7 cells stably transfected with CHIP-HA were transiently trans-
fected with Flag-tagged wild-type or mutant (KR1-3) Src or PKC constructs for 48 h, and then treated with 100 ng/ml LPS for 30 min. Src and PKC 
contained in lysates were immunoprecipitated (IP) with Flag agarose or IgG plus protein A/G agarose as indicated. Ubiquitination was examined by immuno-
blot (IB) using anti-Ub antibody. (G and H) RAW264.7 cells stably transfected with mock vector (RAW264.7-Mock) or CHIP-HA vector (RAW264.7-CHIP) 
were transiently transfected with Flag-tagged Src and PKC mutants (KR1-3) and NF-B (G) or IFN- (H) reporters for 48 h, and then treated with  
100 ng/ml LPS or 1 µM CpG ODN for 4 h. Data are shown as mean ± SD of triplicate samples. **, P < 0.01; ***, P < 0.001 (as compared with corresponding 
RAW264.7-CHIP cells transiently transfected with mock vector and treated with LPS/CpG). In F–H, KR1 indicates for Src-K5/7/9R, KR2 for Src-K324/329R, 
and KR3 for PKC-K220/225R. The data shown in A–C and E–H correspond to a representative experiment out of three performed.JEM Vol. 208, No. 10 
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assembly of TLR 
response by link-
ing  K63-linked 
polyubiquitinated 
Src  and  PKC  
to TLR signaling 
components, e.g., 
TRAF6 and p62/SQSTM1 (Samuels et al., 2001). However, 
the detailed effects of CHIP on the formation of TLR com-
plex may need further investigations.
MATERIALS AND METHODS
Mice and reagents. IFNAR/ mice were obtained from The Jackson 
Laboratory. All the animal experiments were approved by the Medical Ethics 
Committee of the Zhejiang University School of Medicine and conducted 
according to the Declaration of Helsinki Principles. Pam3Cys, R848, Poly(I:C), 
and LPS (0111:B4) were purchased from Sigma-Aldrich. Phosphorothioate-
modified  CpG  ODN  synthesized  by  Sybersyn  and  LPS  were  repurified   
as previously described (Wang et al., 2007). Antibodies specific to HA-tag, 
His-tag, Flag-tag, HSC70, TRAF6, IRF3 and ubiquitin, the recombinant 
IRF3/7, Src and PKC proteins, and the agaroses used in immunoprecipita-
tions  were  obtained  from Abcam. Antibodies  specific  for TLR4, TLR9, 
IRAK1,  TBK1,  TRIF, MyD88, IRF7, phospho-Tyr, phospho-Ser and phospho- 
Thr,  and  antibodies  specific  for  total  and  phosphorylated  forms  of 
ERK1/2  (Thr202/Tyr204),  JNK1/2  (Thr183/Tyr185),  p38  (Thr180/
Tyr182), IKK/ (Ser176/180), Src (Tyr416), PKC (Thr410), and IB 
(Ser32/36) were purchased from Cell Signaling Technology. Antibodies for 
-actin and CHIP were obtained from Sigma-Aldrich. Recombinant MBP, 
and antibodies against K48-ubiquitin and K63-ubiquitin, were purchased 
from Millipore. Ubiquitin and derivatives were purchased from Boston Bio-
chem. The pGL3.5X-B-luciferase plasmid was a gift from S.J. Martin (Smurfit 
Institute, Dublin, Ireland; Bouchier-Hayes et al., 2001) and the pRL-TK- 
Renilla-luciferase plasmid was obtained from Promega. IRF3 reporter plas-
mids were a gift from T. Fujita (Tokyo Metropolitan Institute of Medical 
Science, Tokyo, Japan; Shinobu et al., 2002). Fluorescent antibodies used in 
confocal microscopy were purchased from Invitrogen. siRNAs used in this 
study for indicated E3s were obtained from Santa Cruz Biotechnology, Inc.
Construction of expression plasmids. The recombinant vectors encod-
ing mouse CHIP (available from GenBank/EMBL/DDBJ under accession 
no. NM_019719), HSC70 (accession no. NM_031165), Src (accession no. 
inferred that CHIP-mediated production of IFN- may be 
through Src/PKC-dependent activation of IRAK1/TBK1. 
However, one question still remains: how are IRAK1 and 
TBK1 activated by Src/PKC? Detailed examination of phos-
phorylated sites in IRAK1 and TBK1 affected by Src/PKC 
may help to reveal the mechanisms.
However, we have not satisfactorily explained the effects 
of CHIP on NF-B activation. We show that CHIP cannot 
affect TLR4/9-induced  phosphorylation  of  IKK/  on 
Ser176/180 and IB on Ser32/36, but promote the degra-
dation of IB. Previously, Src and PKC have been impli-
cated in the regulation of NF-B by tyrosine or Ser/Thr 
phosphorylation of IKK/, respectively (Leitges et al., 2001; 
Huang et al., 2003; Chang et al., 2004). The lack of increased 
phosphorylation  of  IB  on  Ser32/36  may  suggest  that 
CHIP-mediated  activation  of  Src/PKC  may  not  directly 
promote the phosphorylation of IKK/. Two possibilities 
may exist for CHIP-mediated activation of NF-B. Src and 
PKC may directly activate NF-B through IB phosphory-
lation, which is supported by the report that Src can mediate 
tyrosine phosphorylation and degradation of IB (Koong   
et al., 1994). Another possibility is that Src and PKC directly 
activate p50/p65 subunits, which is supported by the findings 
that Src and PKC can directly phosphorylate p65 (Savkovic 
et al., 2003; Bijli et al., 2007). However, the final detailed 
mechanisms of CHIP-mediated activation of NF-B (espe-
cially in TLR4 signaling) need further investigations.
We have shown that CHIP is an E3 for Src and PKC. 
Our data suggest that CHIP can ubiquitinate both Src and 
PKC mainly through K63-linked manner. Considering that 
K63-linked polyubiquitination can regulate the activity of 
substrate and the assembly of molecular complexes, we sug-
gest here that CHIP may regulate the activity of Src and 
PKC  by  K63-linked  polyubiquitination.  Supporting  this 
proposal, it has been reported that the crystal structure of 
CHIP indicates for a CHIP-Ubc13–Uev1A complex (Zhang 
et  al.,  2005). Therefore,  CHIP  may  regulate  the  proximal   
Figure 10.  CHIP enhances TRL4- and  
TLR9-triggered DC maturation via IFN-/–
dependent pathway. (A) 48 h after transient 
transfection of siRNAs in day 6 BMDCs, the cells 
were treated with 100 ng/ml LPS or 1 µM CpG 
ODN for 4 h. The mRNA levels of IL-12p40 and 
CD40 were evaluated by quantitative PCR. (B) Day 6 
BMDCs were transiently co-transfected with 
mock vector, CHIP-HA or CHIP mutant-HA vec-
tors, and SrcY416F or PKCT410A vector as indi-
cated for 48 h, and then treated with 100 ng/ml 
LPS or 1 µM CpG ODN for 8 h in the presence or 
absence of 10 nM Src inhibitor (PP1) or 10 µM 
PKC pseudosubstrate peptide (PS). IFN- levels 
were measured by ELISA. In A and B, results were 
presented as mean ± SD of triplicate samples.  
*, P < 0.05; **, P < 0.01; ***, P < 0.001. (C and D) Day 6  
BMDCs derived from wild-type or IFNAR/ mice 
were transiently transfected with mock vector or 
CHIP-HA vector for 48 h, and treated with 100 
ng/ml LPS or 1 µM CpG ODN for 48 h. The expres-
sion levels of DC markers CD40 (C) and CD80 (D) 
were evaluated by FACS assays, and the numbers 
in each panel indicate mean fluorescence inten-
sity. The data shown correspond to one represen-
tative experiment out of three performed.2110 CHIP E3 ligase facilitates TLR signaling | Yang et al.
of CCL5) were amplified from RAW264.7 genomic DNA by nested PCR, 
and the products were inserted into KpnI–Hind III sites of pGL3-Basic vec-
tor (Promega). All constructs were confirmed by DNA sequencing. The de-
termination of reporter transactivation was performed as previously described 
(Wang et al., 2007; Wang et al., 2009).
Flow cytometry. For analysis of phenotypes of BMDCs after treatments, 
cells were stained with fluorescent antibodies (BioLegend) and analyzed by 
flow cytometry as previously described (Chen et al., 2004).
Western blotting and extraction of nuclear proteins. Total cell lysates 
were prepared as previously described (Wang et al., 2007), and protein con-
centration was determined by the BCA protein assay (Thermo Fisher Sci-
entific). Nuclear proteins were extracted by NE-PER Protein Extraction 
Reagent  (Thermo  Fisher  Scientific)  according  to  the  manufacturer’s   
instructions.  Cell  extracts  were  subjected  to  SDS-PAGE,  transferred   
onto nitrocellulose membrane, and blotted as previously described (Chen   
et al., 2004).
Electromobility shift assay (EMSA) of NF-B. Nuclear proteins were 
extracted using NE-PER nuclear extraction reagents (Thermo Fisher Scien-
tific). The  EMSAs  were  performed  using  LightShift  Chemiluminescent 
EMSA kit (Thermo Fisher Scientific) according to the manufacturer’s in-
structions and as previously described (He et al., 2011).
Immunoprecipitation. The  immunoprecipitation  and  the  immunoblot   
assays were performed as previously described (Wang et al., 2009).
GST pull-down assays. The cDNAs encoding CHIP and indicated frag-
ments of CHIP were cloned into pGEX-2T vector (GE Healthcare). The 
expression and purification of GST fusion proteins and the GST pull-down 
assays were performed as previously described (Wang et al., 2009).
In vitro kinase assays. For in vitro kinase assays, 100 µg proteins contained 
in total cell extracts were immunoprecipitated with indicated antibodies plus 
protein A/G beads by gently rocking at 4°C for 2 h, followed by centrifuga-
tion at 4°C for 5 min. Next, the in vitro kinase activity assay kits for Src and 
PKC from Cell Signaling Technology were used as instructed by the manu-
facturer. The kinase activity of IRAK1 and TBK1 was determined by mea-
suring radioactive autophosphorylation of MBP or IRF3/7 as previously 
described (Wang et al., 2009).
Polyubiquitination assays. The in vitro and in vivo polyubiquitination as-
says were performed as previously described (Wang et al., 2009). To deter-
mine the polyubiquitination sites within Src and PKC, the PDM-PUB 
algorithm  was  used  (http://bdmpub.biocuckoo.org/prediction.php),  and 
alignment of multiple Src/PKC sequences of various species was performed 
to  assess  the  evolution  conservation  of  the  predicted  lysine  residues. An 
ELISA method was used to verify these ubiquitination sites. Flag-tagged plas-
mids encoding indicated Src/PKC mutants (lysine to arginine mutation) 
were transiently transfected into RAW264.7 cells, and then the cell lysates 
were prepared after LPS treatments using a buffer containing 25 mM Tris-
HCl, pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, and 1% 
SDS. After heat denaturing for 5 min, Src/PKC was immunoprecipitated 
with Flag agarose (Sigma-Aldrich) and eluted with RIPA buffer containing 
0.2% SDS and 0.1% Tween 20. Next, the supernatants were subjected to 
ELISA assays. In brief, ultra-high-binding 96-well microtiter ELISA plates 
(Thermo Fisher Scientific) were coated overnight with rabbit polyclonal 
ubiquitin antibody (Abcam) in carbonate buffer, followed by three washes in 
PBS plus 0.1% Tween 20 (PBST; Sigma-Aldrich). The plates were blocked 
with 1% BSA in PBST, followed by three washes in PBST. Samples or recom-
binant ubiquitin proteins were added to the wells and incubated for 1 h, fol-
lowed  by  three  washes  in  PBST.  Mouse  monoclonal  anti-ubiquitin 
(Sigma-Aldrich) was added to each well and incubated for 1 h, followed by 
three washes with PBST. Anti–mouse IgG HRP-conjugated antibody was 
NM_009271), PKC (accession no. NM_008860), and TRAF6 (accession 
no. NM_009424) were constructed by PCR-based amplification, and then 
subcloned into the pcDNA3.1 eukaryotic expression vector (Invitrogen). 
Vectors encoding HA-tagged CHIP (termed as CHIP-HA), GFP-tagged 
CHIP  (termed  as  CHIP-GFP),  or  Flag-tagged  HSC70,  Src,  PKC,  and 
TRAF6 were constructed and prepared as previously described (Wang et al., 
2007). Mutant forms of CHIP, namely CHIPK31A (mutation of Lys31 into 
Asn, HSC70-binding deficiency), CHIPH261Q (mutation of His261 into 
Gln, E3 activity deficiency), CHIPTPR (truncation of the N-terminal tetra-
tricopeptide repeat), CHIPU (truncation of the C-terminal U box do-
main), and CHIPN20 (deletion of the N-terminal myristylation sequence) 
were  prepared  by  using  MutanBest  kit  according  to  the  manufacturer’s   
instructions (TaKaRa Bio Inc.). All the clones were confirmed by DNA   
sequencing. Primer sequences used in cloning are available upon request.
Cell preparation, cell culture, and transfection. RAW264.7 macro-
phages, HEK293 cells, HEK293 cells stably transfected with mock vector or 
TLR3 vector (Invitrogen), and primary peritoneal macrophages were ob-
tained or prepared as previously described (Wang et al., 2007; Wang et al., 
2009). MEFs deficient for MDA-5 were gifts from S. Akira (Research Insti-
tute for Microbial Diseases, Osaka, Japan). BMDCs were generated by cultur-
ing C57BL/6 BM cells for 10 d (pDCs) in medium containing 40 ng/ml 
Flt-3 ligand (R&D Systems) or for 6 d (BMDCs) in medium containing   
20 ng/ml recombinant GM-CSF and 10 ng/ml IL-4 (Genzyme), as previ-
ously described (Chen et al., 2004; He et al., 2011). CD11c+ BMDCs were 
isolated  using  MACS  cell  separation  reagents  (Miltenyi  Biotec),  and 
CD11c+B220+ pDCs were sorted by using FACS Vantage flow cytometer (BD). 
For transient transfection of plasmids in RAW264.7 cells, jetPEI reagents were 
used (Polyplus Transfection Company). For transient transfection of BMDCs, 
jetPEI-Macrophage reagents were used (Polyplus Transfection Company). 
Stable cell lines overexpressing CHIP and its mutants were selected in   
600 µg/ml G418 for 3–4 wk.
RT-PCR  and  quantitative  PCR. Total  cellular  RNA  was  extracted   
using TRIzol reagent (Invitrogen). RT-PCR was performed as previously 
described (Chen et al., 2004). Specific primers used for RT-PCR assays were 
5-GTGCGCAAGAGCTCAAGGAGC-3  (sense)  and  5-GCCGTTCT-
CAGAGATGAAAGCG-3 (antisense) for CHIP, and 5-AGTGTGACGTT-
GACATCCGT-3  (sense)  and  5-GCAGCTCAGTAACAGTCCGC-3 
(antisense) for -actin. Quantitative PCR was performed on a MJR Chromo4 
Continuous Fluorescence Detector (Bio-Rad Laboratories) according to the 
manufacturer’s protocol and as previously described (Wang et al., 2007).
RNA interference. We have synthesized and selected four siRNA du-
plexes (siRNA1-4; Shanghai GenePharma Co.). For transient transfection, 
21-nt sequences of CHIP siRNA (siRNA4) were synthesized as follows:   
5-AUACAUGGCAGAUAUGGAUUU-3 (sense), and 5-AAAUCCAUAU-
CUGCCAUGUAU-3 (antisense). The sequences 5-AUACAUGCCAGA-
UAUGCAUUU-3 (sense) and 5-AAAUGCAUAUCUGGCAUGUAU-3 
(antisense) were used as a scrambled RNA interference control (CTRL). 
siRNA  duplexes  were  transfected  into  macrophages  and  DCs  using   
INTERFERin-HTS according to the standard protocol (Polyplus Transfection 
Company). For stable knockdown of CHIP, an expression vector (psilencer-U6 
neo; Invitrogen) with insertion of the specific siRNA duplexes of CHIP or 
the  scrambled  siRNA  duplexes  were  transfected  into  RAW264.7  cells 
(Wang et al., 2007). To exclude the possibility of off-target effects of the 
siRNA4, a plasmid (CHIP-R4) resistant to siRNA-4 was constructed and 
transfected into CHIP-silenced cells.
Measurement of cytokines. ELISA kits for mouse IL-6, TNF, and IFN- 
were obtained from R&D Systems. Cytokine concentrations in culture superna-
tants were measured by ELISA as previously described (Wang et al., 2007).
Luciferase reporter assays. The IFN- luciferase reporter plasmids were 
constructed by us as previously described (Wang et al., 2007). For construc-
tion of IL-6 and CCL5 reporter, DNA sequences (-256-+1 of IL-6 and -979-+8 JEM Vol. 208, No. 10 
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added to the 96-well plates, followed by three washes with PBST. Finally, the 
substrate TMB was added, and absorbance was read by spectrophotometer 
(Bio-Rad Laboratories) at 450 nm.
Immunofluorescence staining and confocal microscopy. RAW264.7 
cells  transiently  transfected  with  plasmids  encoding  CHIP-GFP  and 
CHIPN20-GFP were cultured on coverslips for 48 h. For the colocaliza-
tion analysis of CHIP or TLR4 with early endosome marker EEA1, TLR4, 
PKC or Src, wild type or transfected RAW264.7 cells were immunostained 
with first antibody against EEA1, TLR4, PKC or Src as indicated, and then 
with proper Oregon Green 488– or Alexa Fluor 555–conjugated secondary 
antibodies. The immunostaining process was performed as described (Wang 
et al., 2007). Slides were finally examined under a fluorescence confocal   
microscopy (LSM confocal microscope; Carl Zeiss, Inc.) as previously described 
(Wang et al., 2007).
Statistical analysis. All the experiments were independently repeated at 
least three times. Results are given as mean ± SEM or mean ± SD. Compari-
sons between two groups were done using Student’s t test analysis. Multiple 
comparisons were done with a one-way ANOVA, followed by Fisher’s least 
significant difference analysis, or done with Kruskal-Wallis tests. Statistical 
significance was determined as P < 0.05.
Online supplemental material. Fig. S1 shows the effects of silencing sev-
eral E3 ligases or A20 DUB on production of TNF or IFN- by DCs during 
TLR4 response. Fig. S2 shows the effects of transient transfections of four 
CHIP siRNAs, or the siRNA4-resistant CHIP mutant on CHIP expression 
and on TNF or IFN- production by DCs during TLR4 response. Fig. S3 
shows the expression pattern of CHIP in immune cells, the efficiency of 
CHIP siRNA on reducing CHIP expression, and the production of TNF 
by CHIP-silenced peritoneal macrophages after TLR ligands activation. Fig. S4 
shows the effects of CHIP knockdown on IL-12p70 production and matu-
ration of BMDCs. Fig. S5 shows the effects of CHIP silence on TLR3 sig-
naling. Fig. S6 shows the effects or CHIP silence or CHIP overexpression 
on the kinase activity of Src and PKC. Fig. S7 shows that the localization 
and E3 ligase activity of CHIP are required for its roles in TLR response. 
Fig. S8 shows that knockdown of CHIP impairs TLR4 and TLR9 response 
in BMDCs. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20102667/DC1.
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